Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
about
Emerging treatments for primary sclerosing cholangitis.Vitamin A deficiency in chronic cholestatic liver disease -is vitamin A therapy beneficial ?Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.Cholestatic liver diseases: new targets, new therapies
P2860
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@en
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@nl
type
label
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@en
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@nl
prefLabel
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@en
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@nl
P2093
P2860
P1476
Combination Therapy of All-Tra ...... langitis: A Human Pilot Study.
@en
P2093
Andrea A Gossard
David N Assis
James L Boyer
Jill C Keach
John E Eaton
Keith D Lindor
Kenneth D R Setchell
Osama Abdelghany
Shi-Ying Cai
Yanhong Deng
P2860
P304
P356
10.1097/MCG.0000000000000591
P577
2017-02-01T00:00:00Z